Does 23andMe Affect UK Life Insurance?

If you spat into a 23andMe or AncestryDNA tube a couple of years ago and have now reached the family-history questions on a life insurance application, here is the reassurance you came for. Does 23andMe affect life insurance in the UK? For the predictive health result itself, no. A UK insurer that has signed the industry Code cannot ask you for the result of a shop-bought DNA kit, cannot require you to take one, and cannot take an unfavourable predictive result into account when it prices your cover.

This surprises people, because almost everything that turns up when you search is written for an American reader, where the rules are genuinely different. So before you talk yourself into disclosing something you do not need to — or worse, into not applying at all — it is worth understanding exactly what a direct-to-consumer genetic test does and does not do to a UK application.

The rest of this page sets out the clause that governs it, why the American answer misleads, the single narrow exception, and the one situation where a kit result genuinely does become relevant. That situation is not about the result. It is about what you did after you read it.

So does a 23andMe result affect a UK application?

Separate two things that are easy to blur together: the genetic result, and the duty to disclose. The genetic result — the part of your 23andMe or Ancestry report that estimates your risk of a condition you do not yet have — is a predictive result. Under the UK arrangement that governs this, a predictive result cannot be requested by a life insurer and cannot be held against you. That is true whether the sample went to an NHS genetics laboratory or to a company you paid online.

The duty to disclose is narrower than people fear. In the UK you answer the questions the insurer actually asks, taking reasonable care to answer them accurately. There is no open-ended obligation to tell an insurer everything you happen to know about your own DNA. If the insurer is not allowed to ask about a predictive kit result, and you are not obliged to volunteer it, then in practice the result sits outside the application entirely.

Where the American internet tells you to buy cover quickly before a test can count against you, the honest UK answer is that the rush is unnecessary for the result itself. The thing you are trying to outrun cannot be used anyway. That does not make timing irrelevant in every case — the section below on what happens after a test explains when it can matter — but the panic that drives most of these searches is misplaced.

The clause that does the work: the Code on Genetic Testing and Insurance

The protection comes from the Code on Genetic Testing and Insurance, an agreement between HM Government and the Association of British Insurers. It replaced an earlier concordat and moratorium in 2018 and is adhered to by ABI member insurers, who write the overwhelming majority of UK life cover. It is a commitment rather than a statute, but it is the settled market practice, and a complaint that an insurer has breached it can be escalated.

Stripped to its effect, the Code's position is this. An insurer will not ask you to take a predictive genetic test, will not ask you to disclose the result of one, and will not take an adverse predictive result into account. Crucially for anyone holding a shop-bought report, that protection is not limited to tests done through the NHS. The Code's definition of a predictive genetic test reaches results obtained in a clinical setting, results obtained through research, and results from a test bought directly by the consumer.

In other words, the kit on your bathroom shelf is treated identically to a test ordered by an NHS consultant. There is no separate, weaker rule for the commercial version. A person who has never been near a genetics clinic, and a person referred to one and tested there, stand in exactly the same place when it comes to a predictive result.

Source: HM Government and the Association of British Insurers, Code on Genetic Testing and Insurance.

Predictive, diagnostic, and where a shop-bought kit sits

The word that decides everything is predictive. A predictive genetic test looks at someone with no symptoms and estimates the chance a condition might develop. A diagnostic test is different: it is used to confirm or explain a condition a person already appears to have. The Code protects predictive results. It does not extend the same shield to a diagnostic test that formed part of working out why you were already unwell.

A 23andMe or AncestryDNA health report is, almost by definition, predictive. You ordered it out of curiosity or interest, not because a doctor was investigating a symptom. So the risk estimates it hands back — for clotting factors, for carrier status, for a raised or lowered chance of some later illness — are the protected kind. If your report flagged something specific that alarmed you, such as an Alzheimer's-associated variant, the same logic applies, and it is worth reading how an APOE result on an ancestry report sits with UK life cover rather than assuming the worst.

Because the boundary between "the result" and "everything the result touches" is where people go wrong, it is worth being precise about the disclosure question on its own terms. We set that out in detail in the companion piece on whether you must declare a 23andMe result to a life insurer. The short version is that the result stays off the form; a medical consequence of acting on it may not.

Why the American answer is wrong here

Most of the confusion is imported. In the United States, the federal Genetic Information Nondiscrimination Act restricts the use of genetic information in health insurance and in employment. It does not cover life insurance. Life cover in America is regulated state by state, and a number of states permit life insurers to ask about and use genetic test results, including results from consumer kits. That is the origin of all the advice you will read about buying a policy before you test, freezing your DNA data, or never linking a kit to your real name.

None of that reasoning transfers to the UK, because the UK did not solve the problem through a health-insurance-only law. It solved it through a separate agreement — the Code — that deals specifically with life, critical illness and income protection cover, and that puts predictive results out of reach regardless of where the test was done. Reading American forums and applying their conclusions to a British application is the single most common way people frighten themselves unnecessarily on this topic.

So when a US article tells you that your Ancestry DNA result could raise your life insurance or get you declined, the accurate UK translation is: not for the predictive result, and not because a UK insurer asked for it. The mechanism that makes the American warning true simply does not exist here.

The one exception: Huntington's disease over £500,000

There is a single, deliberately narrow exception, and it is worth stating plainly so nobody is caught out by it. For life insurance, an insurer may ask about the result of a predictive test for Huntington's disease, and only where the total amount of life cover applied for is more than £500,000. Below that figure, even a Huntington's result cannot be asked about. No other condition is on the list, and consumer kits do not generally report a clinical Huntington's result in the first place.

Critical illness cover and income protection are also within the Code, each with its own separate financial limits, and at present no predictive test is approved for use with those products at all. The threshold arrangement exists so that the protection is close to absolute for ordinary family-sized policies, with a tightly bounded exception at the very top of the market for the one condition where the evidence was judged to justify it.

Source: HM Government and the Association of British Insurers, Code on Genetic Testing and Insurance.

When your kit result becomes relevant anyway

Here is the part that genuinely matters, and the part most reassurance articles skate over. The gene result is protected. What you did after reading it may not be. If your report worried you enough to see your GP, and that led to a referral, a scan, a blood test, a diagnosis or a course of medication, then those are ordinary items of medical history. If the application asks about investigations, symptoms, appointments or treatment — and most do — you answer them accurately, exactly as you would for anything else in your notes.

The distinction is clean once you see it. An insurer cannot say "tell us your 23andMe result." An insurer can ask "have you seen a doctor about any symptom in the last five years" or "are you awaiting any test results," and a truthful answer there is required whether or not a DNA kit set the chain of events in motion. The protection attaches to the predictive result, not to the entire medical trail that may have followed it.

This is also why timing can still matter in a specific case: not to beat the gene result, which cannot be used, but where a kit finding has already sent you into active investigation. If you are mid-application and mid-referral at once, read what has to be said when you are applying for cover while you wait for test results before you fill anything in, because that scenario has its own rules.

What you do still have to answer

Setting the DNA kit aside, an ordinary application still asks about your own health honestly reported. The governing standard is the Consumer Insurance (Disclosure and Representations) Act 2012, which requires you to take reasonable care not to make a misrepresentation when you answer the insurer's questions. That means your height and weight, your smoking status, your alcohol use, your current conditions and medications, and the family-history questions the form actually poses.

Those family-history questions ask about your relatives' real diagnoses and ages — not about your gene report. If a parent or sibling has had a heart attack or a cancer at a young age, that is the sort of thing they are getting at, and it is answered from what happened to your family, not from a probability score on a website. If you cannot answer because you do not have that information, that too has an honest answer; people who were adopted and have no family medical history to give face exactly this, and "not known" is accepted.

It also helps to keep the fear proportionate. A raised relative risk on a consumer report is not the same as a high absolute chance of anything, and the underlying odds for most people are lower than the report's framing suggests. If your parents died young and that is really what is driving this, the honest starting point is the baseline probability set out in both my parents died before 60, what are my odds and the untangling of the four different figures people call the average age of death. Once you are comfortable that the kit result changes nothing on the form, you can get life insurance quotes and answer only the questions that are actually asked.

Does the position differ in Scotland or Northern Ireland?

No. The Code on Genetic Testing and Insurance is an agreement between HM Government and the Association of British Insurers that applies across the whole of the United Kingdom, so the protection for a consumer DNA result is the same in Scotland, Wales and Northern Ireland as it is in England. The Consumer Insurance (Disclosure and Representations) Act 2012, which sets the reasonable-care standard for answering an insurer's questions, is likewise UK-wide.

What can differ between the nations is the clinical pathway that follows a worrying result — which NHS service you are referred to, and how quickly — but that affects your care, not the insurance rule. Wherever you live in the UK, a predictive result from a shop-bought kit stays outside a life insurance application.

Frequently asked questions

Do I have to tell a UK insurer about a 23andMe result?

No. The Code on Genetic Testing and Insurance covers direct-to-consumer tests in the same way as NHS ones. Insurers will not ask for, and you need not volunteer, a predictive result from a shop-bought kit. The sole exception is a predictive test for Huntington's disease where the total life cover applied for is above £500,000.

Is the American answer different?

Yes, and that is why so much online advice misleads UK readers. US federal law restricts genetic discrimination in health insurance and employment but not in life insurance, where several states permit insurers to use results. The UK position rests on a separate agreement between government and the ABI, which puts predictive results out of reach whatever the amount.

What if my kit result led to a doctor's appointment?

Then the medical part is disclosable. The genetic result itself stays protected, but symptoms, a diagnosis, tests and treatment that follow are ordinary medical history. If an insurer asks about investigations or conditions, those must be answered with reasonable care, even though the test result itself cannot be requested.